GTJA: Innovent Bio's Marziditide is expected to be approved by 25H1, maintaining a "shareholding" rating.
GTJA released a research report stating that Innovent Bio (01801) had intensive clinical data readings on its integrated pipeline and tumor pipeline. PD-1/IL2, CLND18.2ADC, and CLDN18.2/CD3 clinical data were excellent, and Marizomib is expected to be approved soon with enormous market potential. GTJA maintains a 'shareholding' rating, stating that it is optimistic about the company's integrated pipeline and Marizomib's layout in the IO+ADC tumor field, and its increase in domestic sales. GTJA's main viewpoints are as follows: Marizomib effectively reduces weight and decreases liver fat by more than 80%, indicating its potential entry into the MASH treatment market. According to GLOR.
XLI: 3M, GE Aerospace Among Industrial Gainers During the Second Quarter; American Airlines Among Laggards
3M Young Scientist Challenge Announces 2024 National Finalists
Deutsche Bank Adjusts Price Target on 3M to $110 From $102, Keeps Hold Rating
3M and Discovery Education Recognize 26 State Merit Winners and Four Honorable Mentions in 2024 3M Young Scientist Challenge
Express News | Live On CNBC, Josh Brown Announces Bought 3M
3M's PFAS Uncertainty, Free Cash Flow Constraints Temper Optimism Amid Positive Sentiment, UBS Says
The 30-stock Secret: 'Don't Fight Papa Dow'
3M (MMM) Gains But Lags Market: What You Should Know
Moody's Affirms All Ratings Of 3M Company; Outlook Changed To Stable From Negative
Wells Fargo Maintains 3M(MMM.US) With Hold Rating, Maintains Target Price $100
3M Analyst Moves To 'Outperform' On Strong EPS Outlook
Express News | 3M Shares Rise 1.3% After Wolfe Research Raises to Outperform From Peer Perform
Peeling Back The Layers: Exploring 3M Through Analyst Insights
3M Transfers $2.5 Billion in Pension Obligations to Met Tower Life Insurance
Express News | 3M Expects Transfer Of US Pension Payment Obligations Not To Impact Its Q2 Or 2024 Adjusted Net Income Or Adjusted Free Cash Flow
Express News | 3M Expects To Recognize Estimated Non-Cash Pre-tax Non-Operating Pension Settlement Charge Of $0.8B - $0.9B In June Quarter In Connection With Pension Payment Transfer Transaction
Express News | 3M Co - Settlement Charge Will Not Impact Company's Q2 or Full Year 2024 Adjusted Net Income or Adjusted Free Cash Flow
Express News | 3M Co: Retirees and Beneficiaries Who Are Included in This Annuity Transfer Will Be Notified This Month
Express News | 3M: Expects to Recognize Estimated Non-Cash Pre-Tax Non-Operating Pension Settlement Charge of Between $0.8 & $0.9 Bln in Quarter Ending June 30, 2024